Mesoblast, a leader in allogeneic cellular medicines for inflammatory diseases, has Dr. George as its largest shareholder, according to a Feb. 23 press release.
Dr. George has a background in medical science with experience in operations, having built an ASC startup into a billion-dollar organization, according to the release.
